Position in ANNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$737,977
-$1,637,131 QoQ
Shares Held
129,243
-69.9% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 216 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. ANNX ranks #185 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in ANNX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $737,977 | 129,243 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,375,108 | 428,720 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,234,271 | 445,074 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,478,563 | 484,775 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,219,446 | 508,103 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,012,750 | 524,741 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,665,494 | 1,104,385 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,125,138 | 1,034,652 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,362,912 | 1,094,472 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,490,957 | 1,323,704 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $56,790 | 12,509 | Shares | Defined | 2024-02-16 | |
| 2022-03-31 | $3,616,521 | 1,324,733 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $33,052,903 | 2,876,667 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $32,096,127 | 1,724,671 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $29,498,994 | 1,310,484 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $37,287,810 | 1,339,361 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $30,173,740 | 1,205,503 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $28,851,814 | 954,410 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||